Anti-Inflammatory Effect of FK-506 on Human Skin Mast Cells
- 1 December 1992
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 99 (6), 723-728
- https://doi.org/10.1111/1523-1747.ep12614216
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Human Basophil Releasability. VIII. Increased Basophil Releasability in Patients with SclerodermaArthritis & Rheumatism, 1991
- Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.Proceedings of the National Academy of Sciences, 1990
- Suppression of B cell activation by cyclosporin A, FK506 and rapamycinEuropean Journal of Immunology, 1990
- CyclosporineNew England Journal of Medicine, 1989
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989
- OPTIMAL SERUM TROUGH LEVELS OF FK506 IN RENAL ALLOTRANSPLANTATION OF THE BEAGLE DOGTransplantation, 1989
- Pathophysiology of human basophils and mast cells in allergic disordersClinical Immunology and Immunopathology, 1989
- Human basophil/mast cell releasability. VII. Heterogeneity of the effect of adenosine on mediator secretionLife Sciences, 1989
- Human Basophil Releasability. II. Changes in Basophil Releasability in Patients with Atopic DermatitisJournal of Investigative Dermatology, 1986
- Inhibition of Human Basophil Leukotriene Release by Antiinflammatory SteroidsInternational Archives of Allergy and Immunology, 1985